Page Title
Drug Development Pipeline
Back to the Drug Development Pipeline
Alpha 1 Anti-Trypsin
Status
DiscontinuedTherapeutic Approach
Anti-Inflammatory
Alpha 1 Anti-trypsin is an aerosolized protease inhibitor with anti-inflammatory properties, derived from human plasma.
Status
A Phase 2 trial was completed in the U.S. No further clinical development in CF is planned at this time.
Sponsor
The program was sponsored by Grifols Therapeutics, Inc.
Recent Changes
2/1/2016
This therapy is no longer being pursued by Grifols Therapeutics Inc.

CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.
Learn More